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at an acceptable cost. The objective of this study was to perform a rapid-HTA to 
evaluate the effectiveness of integrated care in reducing the mortality rate of breast 
cancer. Methods: A literature review was performed via PubMed, LILACS, the 
Cochrane Library, Center of Reviews and Dissemination, and REBRATS databases. All 
studies that met the inclusion criteria were appraised according to the GRADE and 
their level of evidence according to the Oxford Centre for Evidence Based Medicine. 
This HTA was performed following the “Rapid-HTA Guideline” published by the 
Brazilian Ministry of Health. Results: 242 studies were retrieved among those 
databases. 3 cohort studies and 1 systematic review met the inclusion criteria. One 
cohort study associated a reduction in the mortality rate, statistically significant, 
after the implementation of the breast cancer integrated care. The systematic review 
concluded that there are few high quality studies evaluating the impact of integrated 
care on the breast cancer mortality. However, its authors didn’t challenge the impact 
of integrated care on the breast cancer management nor its potential psychosocial 
benefits. Intrinsically, they stated, this type of disease management is associated 
to a low rate of mortality, but there is a lack of high quality studies. ConClusions: 
There are few studies assessing the effectiveness of breast cancer integrated care 
programs in reducing the mortality rate among those women. The final recom-
mendation is weak in favor of this health technology and we suggest a systematic 
review to search and evaluate the existing evidence.
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objeCtives: The Affordable Care Act (ACA) was signed into law on March 23, 2010. 
The ACA was developed to increase affordability and accessibility to health care. 
The purpose of this review was to provide an overview of the impact of the ACA 
on pharmacy benefit managers (PBMs) with respect to benefit design changes, 
health care exchanges and challenges. Methods: PubMed, Google Scholar, APhA 
and AMCP websites were searched for articles from 2008 to 2013. This timeframe 
was selected because the ACA became officially recognized in 2010, when signed 
into law. Keywords used in the search were “pharmacy model”, “affordable care 
act”, “pharmacy benefit”, “benefit design changes”, “health care exchange”, and 
“outcomes.” Each reference was evaluated against the following inclusion crite-
ria using a step-wise approach; 1) the article included information on formulary 
changes, health care exchanges or projected outcomes 2) the article mentioned 
benefit designs and pharmacy benefit managers. Articles were summarized based 
upon publication year, methods and findings. Results: A total of 24 articles were 
retrieved. Studies show that there will be 25-30 million newly insured patients over 
7-8 years as a result of the ACA. PBMs will continue to be interested in increasing 
coverage of generic products on plan formularies. The number of medications and 
types of diseases covered through the growth of specialty pharmacy is also projected 
to increase. Under the ACA exchanges, PBMs are required to confidentially disclose 
the percent of all prescriptions provided through retail pharmacies and the types of 
rebates and discounts received. Although challenging, PBMs can expect increases in 
mergers, creating larger PBM companies. ConClusions: With an increase in the 
number of members covered and types of coverage offered, the Affordable Care Act 
is projected to have positive effects on the growth and expansion of services offered 
by PBMs. However, PBMs may face challenges accommodating larger populations.
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objeCtives: To systematically review studies that include educational interven-
tions for health care providers, patients nearing the end-of-life (EoL), and their car-
egivers to improve patient or caregiver quality of life (QoL). Methods: This review 
was conducted according to published guidelines using a pre-specified protocol. 
Patients nearing EOL were defined as having a progressive, life-threatening disease 
with minimal possibility of obtaining remission, stabilization or modification of the 
course of illness. Primary studies including any educational intervention in EoL care 
among health care providers, patients and caregivers measuring patient or caregiver 
QoL using validated scales were included. Results: Our search of 11 databases 
revealed 2468 citations. After duplicate removal, title and abstract screening, we 
reviewed 71 full text of which eight were included in the review. There were five 
randomised trials, two cohort studies and one quasi experimental study among 
the eight included studies. Five studies were from United States, one each from 
Spain, Saudi Arabia and China. Patient population included those with advanced 
cancer in five studies (4 RCT’S and 1 cohort study) and advanced chronic disease in 
three studies (1 cluster randomised, 1 quasi-experimental and 1 cohort study). The 
educational intervention was described among clinicians, nurses, EoL patients and 
their caregivers. Comparators were usual/standard care in five studies with a pre-
post impact evaluation in three other studies. All included studies defined and used 
validated scales to measure QoL. Patient QoL was reported in seven of the included 
studies, of which four studies showed improvement (P< 0.001) and three showed 
no significant change (p> 0.05) in patient’s QoL. Of the four studies that reported 
caregiver QoL, three showed improved QoL whereas one study showed decline in 
caregivers QoL (p= 0.02). ConClusions: This review may help shape Ontario health 
policy to provide appropriate education to anyone involved in EoL care.
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TIP-records, time period, beneficiary age, gender, and drug plan (MA-PD, PDP). A 
generalized linear mixed model was fitted for the assessment, using AIC for model 
selection. Results: Each additional TIP-record generated was significantly associ-
ated with a higher total drug cost (p < .0001); however, this effect was attenuated 
over time, as would be expected when the TIP-record was successfully acted upon. 
A successful TIP-record was associated with an 18% reduction in cost at the begin-
ning of the study, falling to 7% at 18 months. On average, MA-PD beneficiaries had 
a cost which was 1.62 times higher than those from the PDP; male beneficiaries had 
an average cost which was 4.8% higher than their counterparts. ConClusions: 
Cost-management TIP-records demonstrated a significant decrease in total pre-
scription drug cost upon successful completion, suggesting targeted medication 
reviews could be used as a drug cost saving strategy for Medicare Part D plans.
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objeCtives: While the use of acupuncture services covered by National Health 
Insurance (NHI) in Taiwan increased, it is unclear how reasonable its utilization is. 
The aim of this study was to explore the acupuncture service utilization among the 
elderly and its potential contributing factors. Methods: The retrospective cohort 
study was conducted using two million random samples of Taiwan National Health 
Insurance Research Databases. Those elderly patients without cancer diseases and 
ever used acupuncture services among the Chinese medicine (CM) users in 2008 
were considered as acupuncture users. Their counterpart non-acupuncture elderly 
CM users were identified based upon the pre-specified propensity score matching 
approach. The demographic characteristics, disease statuses, health care utiliza-
tion, anti-blood clotting medications, pain medications among these two groups 
were compared using descriptive statistics, Chi-square and ANOVA. The univariate 
and multivariate logistic regression tests were performed to explore the factors 
associated with the ever use of acupuncture services. Results: Of 47,273 elderly 
patients ever used CM service , 12520 (32.3%) ever utilized acupuncture services 
in 2008. 12,494 elderly patients in each group were identified. After adjusting for 
other factors, those CM use elderly who made outpatients visits more than 2 times, 
with neurovascular diseases, diabetes mellitus, lower back pain, ever took aspirin, 
warfarin, NSAID, gabapentin during six months before the first use of CM tended 
to use acupuncture services. In contrast, those CM use elderly who were aged 
75 to 84, prescribed with more than 10 items of medications, with chronic lung 
disorders, osteoporosis tended not to use acupuncture services. ConClusions: 
Approximately one-third of CM use elderly ever made acupuncture services. More 
attention should be made towards those patients who made more outpatient visits, 
with certain chronic disorders and ever took blood-clotting and pain medications. 
Further study to explore the corresponding outcomes of acupuncture uses among 
the elderly is needed.
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objeCtives: Reducing readmissions is a National Health Service (NHS) Key 
Performance Indicator. Ambulatory care units may provide financial savings, but 
high quality and effective service delivery is dependent on having an understanding 
of an individual hospital’s admissions. Comparison of patients with single or mul-
tiple comorbidities on admission or in other words multiple admission diagnoses, 
may help plan and deliver appropriate health care and support services in the most 
appropriate setting. We compared patients with multiple admission diagnoses to 
patients with one single admission diagnosis, to investigate whether there are dif-
ferences in patient demographics, length of stay and readmission. Methods: We 
conducted a retrospective audit of all non-elective adult acute medical admissions 
over a 6 week period. We collected information on patient demographics, ICD-10 
diagnosis and length of hospital stay. We reviewed all electronic discharge sum-
maries and grouped admissions according to ICD-10 classification. We matched 
patients with multiple diagnoses to patients with similar ICD-10 diagnosis, without 
other co-morbidities. The length of stay, and readmission rates were also recorded 
and compared. Results: A total of 863 admissions were analysed. We matched 41 
patients with multiple co-morbidities and same admission diagnoses to patients 
discharged with a comparable single ICD-10 diagnosis. Both groups had similar 
female to male ratio. The mean age in both groups was 65 (p= 0.42). However, the 
length of stay was statistically significant (p= 0.002) between the two groups (multi-
ple diagnosis 12 days vs 6 days for single diagnosis). Moreover, patients with multiple 
admission diagnoses had higher readmission rates within a week and a month (0 
patients with single admission diagnosis vs 5 patients with multiple admission diag-
noses). ConClusions: Both groups had similar demographics, but co-morbidities 
can lead to longer hospital stay, and increase risk of hospital readmission. Patients 
with multiple co-morbidities should have more detailed discharged planning by 
multidisciplinary team. Patients without multiple co-morbidites can be safely man-
aged in an ambulatory care setting.
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objeCtives: Breast cancer is one of the commonest cancers worldwide. The care 
management of patients with cancer is complex, which may lead to suboptimal, 
fragmented and discontinuous treatment. Integrated care pathways have begun 
to receive greater attention and support because of the possibility to reduce this 
fragmentation and achieve better results for the patient and the health care system 
